Robin J. Taylor, MD
Cardiology:
Taylor RJ. Telmisartan did not reduce a composite of CV death, MI, HF, or stroke in high-risk patients intolerant to ACE inhibitors. Ann Intern Med. 2009;150:JC2–6. doi: https://doi.org/10.7326/0003-4819-150-4-200902170-02006
Download citation file:
© 2019
Published: Ann Intern Med. 2009;150(4):JC2-6.
DOI: 10.7326/0003-4819-150-4-200902170-02006
Cardiology, Coronary Risk Factors, Hypertension, Nephrology, Neurology.
Results provided by: